MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,497,284 | -19.9% | 17,100 | +26.7% | 0.01% | -33.3% |
| Q2 2023 | $3,118,500 | -8.1% | 13,500 | -3.6% | 0.01% | +28.6% |
| Q1 2023 | $3,391,640 | -18.3% | 14,000 | -2.1% | 0.01% | -41.7% |
| Q4 2022 | $4,150,575 | -41.6% | 14,300 | -86.9% | 0.01% | -45.5% |
| Q3 2022 | $7,106,000 | +513.1% | 109,336 | +574.9% | 0.02% | +450.0% |
| Q2 2022 | $1,159,000 | +412.8% | 16,200 | +604.0% | 0.00% | +300.0% |
| Q1 2022 | $226,000 | +5.6% | 2,301 | -8.7% | 0.00% | 0.0% |
| Q4 2021 | $214,000 | -92.9% | 2,520 | -90.1% | 0.00% | -94.1% |
| Q3 2020 | $3,028,000 | -1.3% | 25,500 | -5.9% | 0.02% | -15.0% |
| Q2 2020 | $3,067,000 | +326.0% | 27,085 | +242.8% | 0.02% | +300.0% |
| Q4 2019 | $720,000 | -40.2% | 7,900 | -31.3% | 0.01% | -50.0% |
| Q2 2019 | $1,205,000 | -2.9% | 11,500 | +16.2% | 0.01% | 0.0% |
| Q1 2019 | $1,241,000 | +12310.0% | 9,900 | +21421.7% | 0.01% | – |
| Q3 2018 | $10,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |